» Articles » PMID: 20006563

Osteoclast Function, Bone Turnover and Inflammatory Cytokines During Infective Exacerbations of Cystic Fibrosis

Overview
Journal J Cyst Fibros
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2009 Dec 17
PMID 20006563
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Raised levels of pro-inflammatory, pro-resorptive cytokines during pulmonary infection may contribute to osteoporosis in cystic fibrosis (CF). We assessed osteoclast number and activity during infective exacerbations and examined their relationship to serum inflammatory cytokines and bone turnover markers.

Methods: Serum samples from 24 adults with CF were obtained before, during and after treatment of infection. Osteoclastic cells were generated from peripheral blood mononuclear cells and their number and activity assessed. Serum osteocalcin, type 1 collagen cross-linked N-telopeptide (NTx), interleukin-6 (IL-6), tumour necrosis factor alpha (TNFalpha), receptor activator of NFkB ligand (RANKL) and osteoprotegerin (OPG) were measured.

Results: Osteoclast number and activity were increased at the start of exacerbation and decreased with antibiotic therapy. Significant correlations were demonstrated between osteoclast formation and serum TNFalpha, OPG, osteocalcin and NTx and between osteoclast activity and serum IL-6 and NTx.

Conclusions: The systemic response to infection is associated with increased bone resorptive activity in patients with CF.

Citing Articles

A Novel Formulation Based on Resveratrol and Water Extracts from , , , and Inhibits the Gene Expression of Inflammatory and Osteoclastogenic Biomarkers on C2C12 Cells Exposed to Oxidative Stress.

Di Simone S, Acquaviva A, Libero M, Nilofar N, Tunali F, Gabriele M Foods. 2025; 14(5).

PMID: 40077599 PMC: 11899544. DOI: 10.3390/foods14050896.


Pulmonary exacerbations in early cystic fibrosis lung disease are marked by strong modulation of CD3 and PD-1 on luminal T cells.

Giacalone V, Giraldo D, Silva G, Hosten J, Peng L, Guglani L Front Immunol. 2023; 14:1194253.

PMID: 37809107 PMC: 10551126. DOI: 10.3389/fimmu.2023.1194253.


Changes of androgen and corticosterone metabolites excretion and conversion in cystic fibrosis.

Podgorski R, Suminska M, Rachel M, Pikula B, Fichna P, Bidlingmaier M Front Endocrinol (Lausanne). 2023; 14:1244127.

PMID: 37711888 PMC: 10497873. DOI: 10.3389/fendo.2023.1244127.


Changes in bone turnover after high-dose vitamin D supplementation during acute pulmonary exacerbation in cystic fibrosis.

Wu M, Bhimavarapu A, Alvarez J, Hunt W, Tangpricha V Bone. 2023; 174:116835.

PMID: 37390941 PMC: 10428002. DOI: 10.1016/j.bone.2023.116835.


Cystic Fibrosis Bone Disease: The Interplay between CFTR Dysfunction and Chronic Inflammation.

Fonseca O, Gomes M, Amorim M, Gomes A Biomolecules. 2023; 13(3).

PMID: 36979360 PMC: 10046889. DOI: 10.3390/biom13030425.